NCT06158568

Brief Summary

Based on the available literature, application of percutaneous electrical nerve stimulation interventions targeting peripheral nerves (also called percutaneous neuromodulation) has shown positive effects for improving pain-related and functional outcomes in musculoskeletal chronic pain. Studies investigating the use of this intervention for the shoulder are lacking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 6, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2024

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

2 months

First QC Date

November 27, 2023

Last Update Submit

April 27, 2024

Conditions

Keywords

NeuromodulationPercutaneous Nerve StimulationExercise

Outcome Measures

Primary Outcomes (1)

  • Changes in disability between baseline and follow-up periods

    The Disabilities of the Arm, Shoulder and Hand (DASH) will be used to determine the disability induced by shoulder pain

    Baseline, one week after the last intervention and 1 and 3 months after the intervention

Secondary Outcomes (3)

  • Changes in shoulder pain between baseline and follow-up periods

    Baseline, one week after the last intervention and 1 and 3 months after the intervention

  • Changes in sleep quality between baseline and follow-up periods

    Baseline, one week after the last intervention and 1 and 3 months after the intervention

  • Changes in anxiety/depressive symptoms between baseline and follow-up periods

    Baseline, one week after the last intervention and 1 and 3 months after the intervention

Study Arms (3)

Percutaneous Electrical Nerve Stimulation

EXPERIMENTAL

Participants assigned to this group will received four sessions (once per week) of ultrasound guided percutaneous electrical nerve stimulation targeting the axillar and suprascapular nerves for 30 minutes. We will apply a biphasic compensated electrical current at a frequency of 2 Hz, a pulse width of 250 μs and intensity allowed over a pain-free motor threshold (muscle contraction). In addition, they will receive a program of exercises for the shoulder musculature for 3 weeks.

Other: Percutaneous Electrical Nerve StimulationOther: Exercise

Placebo Percutaneous Nerve Stimulation

PLACEBO COMPARATOR

Participants assigned to this group will received four sessions (once per week) of placebo ultrasound guided percutaneous electrical nerve stimulation targeting the axillar and suprascapular nerve. The electrical current will be off and no electrical current will be provided to the patient. In addition, they will receive the same program of exercises for the shoulder than the experimental group for three weeks.

Other: Placebo Percutaneous Electrical Nerve StimulationOther: Exercise

Exercise

ACTIVE COMPARATOR

Participants assigned to this group will receive the same program of exercises for the shoulder than the remaining groups for three weeks.

Other: Exercise

Interventions

Application of a electrical current percutaneously (at the motor response intensity) targeting the suprascapular and axillar nerves

Percutaneous Electrical Nerve Stimulation

Application of sham electrical current (no intensity) percutaneously targeting the suprascapular and axillar nerves

Placebo Percutaneous Nerve Stimulation

Application of three weeks of progressive exercises targeting the shoulder musculature

ExercisePercutaneous Electrical Nerve StimulationPlacebo Percutaneous Nerve Stimulation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral non-traumatic shoulder pain (positive painful arc during shoulder abduction and a positive Hawkins test on clinical examination)
  • Shoulder pain from at least 3 months
  • Shoulder pain of more than 3/10 points on a NPRS

You may not qualify if:

  • Bilateral shoulder symptoms
  • Younger than 18 or older than 65 years
  • History of shoulder traumatisms, fractures or dislocation
  • Diagnosis of cervical radiculopathy or myelopathy
  • Previous interventions with steroid injections in the shoulder area
  • Comorbid medical conditions, e.g., fibromyalgia syndrome
  • Previous history of shoulder or neck surgery
  • Any type of intervention for the neck-shoulder area during the previous year
  • Fear to needles

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

César Fernández-de-las-Peñas

Madrid, Rest of the World, 28922, Spain

Location

MeSH Terms

Conditions

Shoulder PainMotor Activity

Interventions

Transcutaneous Electric Nerve StimulationExercise

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and AnalgesiaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • César Fernández-de-las-Peñas, PhD

    Universidad Rey Juan Carlos

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

November 27, 2023

First Posted

December 6, 2023

Study Start

December 1, 2023

Primary Completion

January 25, 2024

Study Completion

April 27, 2024

Last Updated

April 30, 2024

Record last verified: 2024-04

Locations